Tests elastic chest compression in people with COPD and hyperinflation
Tests elastic chest compression on exercise ability and breathing in adults with COPD.
Plain-language title generated from the registry record
Registry title: Effect of Elastic Chest Compression on Functional Exercise Capacity and Respiratory Performance in Patients With COPD
Key facts
- Where
- Hsinchu, TaiwanSee the site
Where in Taiwan
- National Taiwan University Hospital - Hsinchu branchHsinchu, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Taiwan University Hospital
- Trial code
- NCT06519474
- Record updated
- 25 July 2024
- Original description
The goal of this clinical trial is to investigate the effects of elastic chest compression on functional exercise capacity and respiratory performance of patients with COPD. The main questions it aims to answer are:Read full original descriptionShow less
Effect of Elastic Chest Compression on Functional Exercise Capacity and Respiratory Performance in Patients With COPD
The goal of this clinical trial is to investigate the effects of elastic chest compression on functional exercise capacity and respiratory performance of patients with COPD. The main questions it aims to answer are:
Is there difference in functional exercise capacity and respiratory performance without or with the use of elastic upper chest compression? Is there difference in functional exercise capacity and respiratory performance between the use of elastic upper chest compression and elastic lower chest compression?
Participants will:
Be evaluated under three conditions on three different days: without elastic compression, with upper chest compression, and with lower chest compression, with the order of compression application randomly assigned.
The functional capacity and respiratory muscle performance of all patients will be evaluated.
The days for evaluation will be at least three days apart from each other.
Inclusion: at least 20 years old; has a clinical diagnosis of COPD without infection or acute exacerbation in the previous four weeks; is capable of cooperating with the required tests and measurements of the study.
Exclusion: has adjusted COPD related medication within the last month; has experienced unstable angina or an acute myocardial infarction within the last month; has any clinical diagnosis that could affect test outcomes (e.g., neuromyopathy); a Mini-Mental State Examination (MMSE) score below 24.